# miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mir-200c-enhances-sensitivity-of-drug-resistant-non-small-cell-lung-cancer-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Guohua Zhou,Zhang Fangli,Guo Yu,Jianfei Huang,Yaqiong Xie,Shuanglei Yue,Ming‐Hui Chen,Hao Jiang,Mengjie Li |
| Citations | 120 |
| DOI | 10.1016/j.biopha.2016.11.100 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2559788800 |
| PMID | 27930974 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Jianfei Huang](https://scholariq.org/researchers/jianfei-huang/)

## Paper journal

- [Biomedicine & Pharmacotherapy](https://scholariq.org/journals/biomedicine-and-pharmacotherapy/)

## Paper primary topic

- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Paper topics

- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.